Safety and Occupational Health Study Section: Notice of Charter Renewal, 43090 [2012-17879]
Download as PDF
<![CDATA[
43090
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
vitae, and a brief summary of relevant
experience and qualifications.
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Data
NICEATM invites the submission of
data for substances tested in
standardized in vivo acute dermal
systemic toxicity tests. Corresponding
acute oral LD50 data for the same
compounds tested dermally would be
particularly useful. Oral data from rat
tests and dermal data from rat and/or
rabbit tests are preferred. Although data
can be accepted at any time, please
submit data by September 6, 2012 to
ensure consideration during the
ICCVAM evaluation process. Relevant
data received after this date will be
considered where feasible. All
information submitted in response to
this notice will be made publicly
available and may be incorporated into
future NICEATM and ICCVAM reports
and publications, as appropriate.
When submitting data, please
reference this Federal Register notice
and provide appropriate contact
information (name, affiliation, mailing
address, phone, fax, email, and
sponsoring organization, as applicable).
NICEATM prefers that data be
submitted electronically as copies of
pages from study notebooks,
spreadsheets, and/or study reports. Each
submission for a substance should
preferably include the following
information, as appropriate: common
and trade name, Chemical Abstracts
Service Registry Number (CASRN),
commercial source, in vivo test
protocols used, extent to which the data
were collected in accordance with
national or international Good
Laboratory Practice guidelines, date and
testing organization, physical and
chemical properties (e.g., molecular
weight, pH, water solubility, log Kow,
etc.), estimated LD50, and incidence of
death and other adverse effects.
Background Information on ICCVAM
and NICEATM
ICCVAM is an interagency committee
composed of representatives from 15
Federal regulatory and research agencies
that require, use, generate, or
disseminate toxicological and safety
testing information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and that
reduce, refine (enhance animal wellbeing and lessen or avoid pain and
distress), or replace animal use. The
VerDate Mar<15>2010
19:21 Jul 20, 2012
Jkt 226001
ICCVAM Authorization Act of 2000 (42
U.S.C. 285l–3) established ICCVAM as a
permanent interagency committee of the
NIEHS under NICEATM. NICEATM
administers ICCVAM, provides
scientific and operational support for
ICCVAM-related activities, and
conducts independent validation
studies to assess the usefulness and
limitations of new, revised, and
alternative test methods and strategies.
NICEATM and ICCVAM welcome the
public nomination of new, revised, and
alternative test methods and strategies
for validation studies and technical
evaluations. Additional information
about NICEATM and ICCVAM can be
found on the NICEATM–ICCVAM Web
site (https://iccvam.niehs.nih.gov).
References
Bronstein AC, Spyker DA, Cantilena LR, Jr,
Green JL, Rumack BH, Giffin SL. 2010.
2009 Annual Report of the American
Association of Poison Control Centers’
National Poison Data System (NPDS):
27th Annual Report. Clinical Toxicology
48: 979–1178.
EPA. 1998. Health Effects Test Guidelines:
OPPTS 870.1200—Acute Dermal
Toxicity. EPA 712–C–98–192.
Washington, DC:U.S. Environmental
Protection Agency. Available: https://
www.epa.gov/ocspp/pubs/frs/
publications/Test_Guidelines/
series870.htm.
ICCVAM. 2008. NICEATM–ICCVAM FiveYear Plan (2008–2012): A Plan to
Advance Alternative Test Methods of
High Scientific Quality to Protect and
Advance the Health of People, Animals
and the Environment. Research Triangle
Park, NC: National Institute of
Environmental Health Sciences.
Available: https://iccvam.niehs.nih.gov/
docs/5yearplan.htm.
OECD. 1987. Test No. 402. Acute Dermal
Toxicity [adopted 24 February 1987]. In:
OECD Guidelines for the Testing of
Chemicals, Section 4: Health Effects.
Paris:OECD Publishing. Available: https://
dx.doi.org/10.1787/9789264070585-en.
OECD. 2001. Test No. 425. Acute Oral
Toxicity—Up-and-Down Procedure
[adopted 17 December 2001]. In: OECD
Guidelines for the Testing of Chemicals,
Section 4: Health Effects. Paris:OECD
Publishing. Available: www.oecd.org/
dataoecd/17/51/1948378.pdf.
Dated: July 12, 2012.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2012–17787 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Safety
and Occupational Health Study Section,
Centers for Disease Control and
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through June 30, 2014.
For more information contact: Price
Connor, Ph.D., Executive Secretary,
Safety and Occupational Health Study
Section, Department of Health and
Human Services, 1600 Clifton Road NE.,
Mailstop E74, Atlanta, Georgia 30333,
telephone 404/498–2511 or fax 404/
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 16, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17879 Filed 7–20–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH); Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
TIME AND DATE: 11:00 a.m.–3:00 p.m.,
August 15, 2012.
PLACE: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
STATUS: Open to the public, but without
a verbal public comment period.
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)]
[Notices]
[Page 43090]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17879]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section: Notice of Charter
Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Safety and Occupational Health
Study Section, Centers for Disease Control and Prevention, Department
of Health and Human Services, has been renewed for a 2-year period
through June 30, 2014.
For more information contact: Price Connor, Ph.D., Executive
Secretary, Safety and Occupational Health Study Section, Department of
Health and Human Services, 1600 Clifton Road NE., Mailstop E74,
Atlanta, Georgia 30333, telephone 404/498-2511 or fax 404/498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: July 16, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-17879 Filed 7-20-12; 8:45 am]
BILLING CODE 4163-18-P
